Biliary effects of liraglutide and sitagliptin, a 12‐week randomized placebo‐controlled trial in type 2 diabetes patients

AIMS: Treatment with glucagon‐like peptide (GLP)‐1 receptor agonists or dipeptidyl peptidase (DPP)‐4 inhibitors might increase gallstone formation; however, the mechanisms involved are unknown. We aimed to assess the effects of these drugs on gallbladder volume and bile acid profile. MATERIALS AND M...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Diabetes Obes Metab
Autori principali: Smits, Mark M., Tonneijck, Lennart, Muskiet, Marcel H.A., Hoekstra, Trynke, Kramer, Mark H.H., Diamant, Michaela, Nieuwdorp, Max, Groen, Albert K., Cahen, Djuna L., van Raalte, Daniël H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Blackwell Publishing Ltd 2016
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129471/
https://ncbi.nlm.nih.gov/pubmed/27451030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12748
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi